Urgent.News

the world's headlines, one feed

Editions

Business

Are shorts in the office appropriate? Readers have largely told us 'no' — with some exceptions

Over 7,000 people have voted so far on Business Insider's LinkedIn poll — so far, a majority say shorts in the office are a no-no.

Abstract editorial illustration

In an ongoing debate, Business Insider's readers have largely voiced their disapproval of wearing shorts in the office, with only a small fraction supporting the idea. Instagram's head of growth, Adam Mosseri, expressed his support for shorts in the workplace, but acknowledged that not all styles are suitable for everyone. A poll conducted on LinkedIn showed that 54% of respondents opposed the practice, while 20% were in favor, and 25% believed that it depends on the situation.

The poll highlighted the evolving views on office dress codes, with Gen Z now a significant presence in the workforce. However, opinions varied regarding what types of shorts would be appropriate, with some suggesting chino shorts could be acceptable, while others believed that basketball shorts should not be allowed. A few respondents proposed temperature-related exemptions, such as wearing shorts if the temperature exceeded 90 degrees.

The comments also revealed a potential double standard, with some arguing that if skirts are acceptable, then shorts should be too, but they should be subject to the same workwear rules as ordinary attire. Overall, the debate emphasizes the shifting norms of dress codes and the influence of working from home on traditional office attire.

Written by urgent.news from Business Insider's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.

Read the original at businessinsider.com →

More in Business

Samsung Bioepis Files Korea’s First Keytruda Biosimilar Application

Domestic approval procedures have begun in earnest as companies move to gain an early foothold in the biosimilar market for Keytruda, the world’s biggest blockbuster drug with annual sales of 46…

  • Samsung Bioepis files first Keytruda biosimilar application in Korea.
  • SB27 biosimilar targets immuno-oncology treatments, developed by Merck.
  • Application covers 16 diseases, Samsung has 11 biosimilars in market.
Bain Capital set to acquire Gong Cha

Bain Capital set to acquire Gong Cha

Bain Capital a leading global private investment firm has agreed to acquire Gong cha Global one of the world s fastest growing tea brands from TA Associates and the company s other shareholders